HuR/miR-124-3p/VDR complex bridges lipid metabolism and tumor development in colorectal cancer
Carcinogenesis · 20.01.2025 · 46 (1)
DOI: 10.1093/carcin/bgae061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, online erschienen am 02.09.2024. Verfasst von Fengxing Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan 430071, China. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, ELAV-Like Protein 1, Lipid Metabolism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Maintaining a balanced lipid status to prevent lipotoxicity is of paramount importance in various tumors, including colorectal cancer (CRC). HuR, an RNA-binding protein family member, exhibits high expression in many cancers possibly because it regulates cell proliferation, migration, invasion, and lipid metabolism. However, the role of HuR in the regulation of abnormal lipid metabolism in CRC remains unknown. We found that HuR promotes vitamin D receptor (VDR) expression to ensure lipid homeostasis by increasing triglyceride (TG) and total cholesterol (TC) levels in CRC, thus confirming the direct binding of an overexpressed HuR to the CDS and 3ʹ-UTR of Vdr, enhancing its expression. Concurrently, HuR can indirectly affect VDR expression by inhibiting miR-124-3p. HuR can suppress the expression of miR-124-3p, which binds to the 3ʹ-UTR of Vdr, thereby reducing VDR expression. Additionally, a xenograft model demonstrated that targeting HuR inhibits VDR expression, blocking TG and TC formation, and hence mitigating CRC growth. Our findings suggest a regulatory relationship among HuR, miR-124-3p, and VDR in CRC. We propose that the HuR/miR-124-3p/VDR complex governs lipid homeostasis by impacting TG and TC formation in CRC, offering a potential therapeutic target for CRC prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan 430071, China.
- Hubei Provincial Clinical Research Center for Intestinal and Colorectal Diseases, Hubei Key Laboratory of Intestinal and Colorectal Diseases, No. 169, Donghu Road, Wuchang District, Wuhan 430071, China.
- Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, No. 106, Zhongshan 2nd Road, Yuexiu District, Guangzhou 510080, Chin…
- Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, F., Bu, L., Li, M., Wang, Y., Zhang, R., Shao, Y., Lin, K., Yang, H., Zhao, Q., & Liu, L. (2025). HuR/miR-124-3p/VDR complex bridges lipid metabolism and tumor development in colorectal cancer. Carcinogenesis, 46(1). https://doi.org/10.1093/carcin/bgae061
Vancouver
Huang F, Bu L, Li M, Wang Y, Zhang R, Shao Y, et al. HuR/miR-124-3p/VDR complex bridges lipid metabolism and tumor development in colorectal cancer. Carcinogenesis. 2025;46(1). doi:10.1093/carcin/bgae061
BibTeX
@article{Huang2025,
author = {Huang, Fengxing and Bu, Luping and Li, Mengting and Wang, Youwei and Zhang, Runan and Shao, Yu and Lin, Kun and Yang, Hong and Zhao, Qiu and Liu, Lan},
title = {HuR/miR-124-3p/VDR complex bridges lipid metabolism and tumor development in colorectal cancer},
journal = {Carcinogenesis},
year = {2025},
volume = {46},
number = {1},
doi = {10.1093/carcin/bgae061}
}
EUVIMED